Stay updated on Clinical Trial HER2+ Breast Cancer: Chemo-free PET Strategy
Sign up to get notified when there's something new on the Clinical Trial HER2+ Breast Cancer: Chemo-free PET Strategy page.

Latest updates to the Clinical Trial HER2+ Breast Cancer: Chemo-free PET Strategy page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedThe page has been updated to reflect the latest version as v2.15.2, replacing the previous version v2.15.0. Additionally, the phrasing regarding the last update has been changed from 'Estimated' to a definitive statement.SummaryDifference0.1%
- Check15 days agoChange DetectedThe webpage has updated its date references, removing older dates from February 2024 and adding new dates in April 2025.SummaryDifference0.5%
- Check22 days agoChange DetectedThe web page has been updated to reflect a new version of a clinical study on HER2-positive breast cancer, including the addition of specific drugs and a revised study description. Notably, the principal investigator's name has been retained, but some detailed descriptions of the study's methodology and patient criteria have been removed.SummaryDifference26%
- Check30 days agoChange DetectedThe web page has been updated from version 2.14.3 to version 2.14.4.SummaryDifference0.0%
- Check37 days agoChange DetectedThe web page has been updated from version 2.14.2 to version 2.14.3.SummaryDifference0.0%
- Check73 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with contact information for assistance.SummaryDifference0.7%
Stay in the know with updates to Clinical Trial HER2+ Breast Cancer: Chemo-free PET Strategy
Enter your email address, and we'll notify you when there's something new on the Clinical Trial HER2+ Breast Cancer: Chemo-free PET Strategy page.